christopher j. sonnenday m.d., m.h.s. · 2019-10-18 · baltimore, md (july 1, 1998 – june 30,...

C.J. Sonnenday, updated 10/1/2019 , of 25

CHRISTOPHER J. SONNENDAY, M.D., M.H.S. The Darrell A. Campbell Jr., M.D., Collegiate Professor of Transplant Surgery

Associate Professor of Surgery Associate Professor of Health Management & Policy

The University of Michigan 1500 East Medical Center Drive, F6686 UH South

Ann Arbor, MI 48109 734-936-9623

[email protected]

EDUCATION AND TRAINING

1989 – 1993 Northwestern University, Evanston, IL Bachelor of the Arts (History - African Studies), (August 1989 - June 1993)

1993 – 1997 Vanderbilt University School of Medicine, Nashville, TN Doctor of Medicine, (August 1993 - May 1997) 1997 – 1998 Intern in Surgery, the Johns Hopkins University School of Medicine,

Baltimore, MD (July 1, 1997 – June 30, 1998) 1998 – 2000 Resident in Surgery, the Johns Hopkins University School of Medicine,

Baltimore, MD (July 1, 1998 – June 30, 2000) 2000 – 2003 Research Fellow, the Johns Hopkins University School of Medicine,

Basic Scientific Training for Gastrointestinal Surgeons Mentor: Robert A. Montgomery, M.D., D.Phil. (July 1, 2000 – June 30, 2003)

2002 – 2004 The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD

Masters in Health Sciences (Clinical Investigation) (August 2002 - December 2004)

2003 – 2005 Senior Resident in Surgery, the Johns Hopkins University School of Medicine, Baltimore, MD (July 1, 2003 – June 30, 2005)

2005 – 2006 Fellow in Surgical Oncology and Assistant Chief of Service

The Johns Hopkins University School of Medicine, Department of Surgery, Baltimore, MD (July 1, 2005 – June 30, 2006)

2006 – 2008 Fellow in Transplantation The University of Michigan, Department of Surgery, Ann Arbor, MI

(July 1, 2006 – June 30, 2008)

CERTIFICATION AND LICENSURE

3/2006 Board Certification, American Board of Surgery, March 2006


Recertification: March 2016 12/2000-9/2007 Maryland State Medical License, # D0056884, expired 9/30/2007 4/2006 - Present Drug Enforcement Agency Registration Number BS9699755, expir. 2/29/2020 6/2006 – Present Michigan State Medical License, # 4301088731, expir. 1/31/2021 7/2006 – Present Michigan Controlled Substance License, #5315028147, expir. 1/31/2021

ACADEMIC APPOINTMENTS

7/2005 – 6/2006 Instructor in Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 7/2006 – 6/2008 Clinical Lecturer, Fellow in Transplantation The University of Michigan, Department of Surgery, Ann Arbor, MI 7/2008 – 8/2015 Assistant Professor of Surgery The University of Michigan, Department of Surgery, Ann Arbor, MI 9/2008 – 8/2015 Assistant Professor of Health Management & Policy The University of Michigan School of Public Health, Ann Arbor, MI 9/2015 – Present Associate Professor of Surgery The University of Michigan, Department of Surgery, Ann Arbor, MI 9/2015 – Present Associate Professor of Health Management & Policy The University of Michigan School of Public Health, Ann Arbor, MI 9/2018 – Present The Darrell A. Campbell Jr., M.D., Collegiate Professor of Transplant Surgery The University of Michigan, Department of Surgery, Ann Arbor, MI

CLINICAL APPOINTMENTS

7/2005 – 6/2006 Staff Surgeon, the Johns Hopkins University School of Medicine, Baltimore, MD 6/2006 – 6/2008 Staff Surgeon, the University of Michigan, Ann Arbor, MI 7/2008 – Present Attending Surgeon, Section of Transplantation The University of Michigan, Department of Surgery, Ann Arbor, MI 6/2009 – Present Attending Surgeon Ann Arbor Veteran Affairs Medical Center 6/2009 – 7/2013 Surgical Director, Liver Tumor Program Ann Arbor Veteran Affairs Medical Center 7/2012 – Present Surgical Director, Adult Liver Transplant Program


Michigan Medicine, Ann Arbor, MI 7/2016 – Present Surgical Director, Multidisciplinary Liver Tumor Program Michigan Medicine, Ann Arbor, MI 7/2014 – Present Surgical Director, Living Donor Liver Transplant Program Michigan Medicine, Ann Arbor, MI 10/2015 – 8/2019 Associate Chair for Clinical Affairs, Department of Surgery Michigan Medicine, Ann Arbor, MI 9/2019 – Present Executive Vice-Chair, Department of Surgery Michigan Medicine, Ann Arbor, MI

RESEARCH INTERESTS

Frailty as a metric in patient selection for liver transplantation and complex surgical care

Quality collaboratives in transplantation

Donor and recipient selection in liver transplantation.

Racial and geographic disparity in complex surgical care, including transplantation.

Transplant utilization and allocation.

Multi-modality therapy of advanced hepatobiliary and pancreatic malignancies.

Preservation strategies for deceased donor organs prior to transplantation.

GRANT SUPPORT

2000-2003 Investigator, Basic Scientific Training for Gastrointestinal Surgeons National Institutes of Health and the Johns Hopkins University

NIH Grant # T32 DK07713 Principal Investigator: Gregory Bulkley, M.D. Annual support: $35,000 2002-2003 Special Student, Graduate Training Program in Clinical Investigation

The Johns Hopkins University Bloomberg School of Public Health Supported by the National Institutes of Health Supplemental educational grant to NIH Grant # T32 DK07713 Principal Investigator: Gregory Bulkley, M.D. Tuition support: $36,000 over 2 years 2003-2006 Co-Investigator and Author, Enhanced utilization of extended criteria and non-

heart-beating donor kidneys (randomized clinical trial) Department of Health & Human Services, Health Resources & Services

Administration, Division of Transplantation HRSA Grant # 1 H39 OT 00133-01 Principal Investigator: Robert A. Montgomery M.D., D.Phil. Annual support: $156,700/yr X 3 yrs


2010 Principal Investigator, “Michigan Meetings 2010: The economy & cancer health disparities”

University of Michigan internal grant Annual support: $50,000 x 1 year, 0.05 FTE

2009-2011 Co-Investigator, “Reducing racial disparities in cancer surgery” Supplement to NCI Senior Scientist Award, 1 K05 CA115571-01 A2

Principal Investigator: John Birkmeyer, MD. Annual support: $62,500 x 2 years, 0.1 FTE

2010-2012 Co-Principal Investigator, “Analytic Morphomics to Improve Pre-Operative Assessment” Blue Cross / Blue Shield Foundation Annual support: $49,000 x 2 years, 0.1 FTE

2011-2014 Principal Investigator, “Frailty and Outcomes in Liver Transplantation” American Association for the Study of Liver Diseases Career Development Award Annual support: $45,000 x 2 years; noncompetitive renewal x 1 year

2016-Present Site Principal Investigator, “Ex vivo normothermic perfusion versus cold storage Randomized clinical trial, OrganOx Annual support: 0.05 FTE

HONORS AND AWARDS

June 2019 Faculty Service Award, The University of Michigan Department of Urology Sept 2018 The Inaugural Darrell A. Campbell Jr., M.D., Collegiate Professor of Transplant Surgery Sept 2017 American Society of Surgeons Advanced Leadership Development Program, Northwestern

University Kellogg School of Management Sept 2013 American Society of Surgeons Leadership Development Program, Northwestern University

Kellogg School of Management Dec 2012 Department of Surgery Leadership Development Program May 2008 Journal of Gastrointestinal Surgery, Best Article Award 2007. March 2008 Most Outstanding Presentation, The University of Colorado Young Investigator’s Forum,

Controversies in Transplantation, Breckenridge, CO. May 2007 The Society for Surgery of the Alimentary Tract Young Investigator Award,

Digestive Disease Week 2007, Washington, D.C. June 2006 The Willam Osler Prize in Medicine, the Johns Hopkins University School of

Medicine June 2006 The G. Melville Williams Surgical Hero Award, the Johns Hopkins University School of

Medicine June 2005 The John L. Cameron Award for Technical Excellence in Surgery, the Johns

Hopkins University School of Medicine June 2005 Anthony L. Imbembo Surgical Resident Teaching Award, the Johns Hopkins

University School of Medicine June 2005 The Gershon Efron Award for Excellence in Clinical Investigation, the Johns

Hopkins University School of Medicine, Department of Surgery June 2003 Upjohn Clinical Research Award, the Johns Hopkins University School of


Medicine, Department of Surgery July 2002 Henry Christian Research Award, American Federation of Medical Research June 2002 George Zuidema Basic Science Research Award, the Johns Hopkins University

School of Medicine, Department of Surgery April 2002 Resident Research Award, Baltimore Academy of Surgery Feb 2001 Young Investigator’s Award, 2nd International Congress on Immunosuppression June 2000 Anthony L. Imbembo Surgical Resident Teaching Award, the Johns Hopkins

University School of Medicine June 1999 Outstanding Second Year Resident, the Johns Hopkins University School of

Medicine, Department of Surgery May 1999 House Staff Teaching Award, the Johns Hopkins University School of Medicine May 1997 Dean’s Award, Vanderbilt University School of Medicine May 1997 H. William Scott, Jr. Society Prize in Surgery, Vanderbilt University School of

Medicine April 1996 Alpha Omega Alpha Medical Honor Society, Vanderbilt University School of

Medicine May 1994 Microbes and Defense Medical Honor Society, Vanderbilt University School of

Medicine August 1993 Mountcastle Scholar, Vanderbilt University School of Medicine June 1993 Cum Laude, Northwestern University Dec 1992 Outstanding Service Award, Chicago Memorial Children’s Hospital Nov 1992 Coach’s Award, Men’s Soccer, Northwestern University 1991-1993 Captain, Men’s Soccer, Northwestern University

MEMBERSHIPS IN PROFESSIONAL SOCIETIES

1. American Medical Association, Member, 1997-Present 2. American College of Surgeons, 1999 – Present. Fellow, 2011. 3. American Society of Transplant of Transplant Surgeons, Member, 2006 - Present 4. Society for Surgery of the Alimentary Tract, Member, 2006 – Present 5. Surgical Outcomes Club, 2006-Present 6. Americas Hepato-Pancreato-Biliary Association, Member, 2007-Present 7. Association for Academic Surgery, Member, 2008-Present 8. International Liver Transplant Society, Member, 2008-Present 9. Academy Health, 2008-Present 10. American Association for the Study of Liver Diseases, 2009-Present 11. Clinical Robotic Surgery Association, 2010-Present 12. International Hepato-Pancreato-Biliary Association, 2013-Present 13. Association of Women Surgeons, 2018-Present 14. Society of Black Academic Surgeons, 2018-Present

EDITORIAL POSITIONS, BOARDS, AND PEER-REVIEW SERVICE 2002-Present American Journal of Transplantation, peer review service 2008-Present Annals of Surgery, peer review service 2008-Present Journal of Surgical Research, peer review service 2008-Present World Journal of Surgery, peer review service 2008-Present HPB, peer review service


2009-Present Clinical Transplantation, peer review service 2009-Present Surgery, peer review service 2010-Present Annals of Surgical Oncology, peer review service 2008-Present American Transplant Congress, peer review service 2008-Present Program Committee, Academic Surgical Congress 2010-Present Editorial Board, Journal of Gastrointestinal Surgery 2010-Present Liver Transplantation, peer review service 2012-Present Gastroenterology, peer review service 2012-Present Americas Hepato-Pancreato-Biliary Association Annual Meeting, peer review service 2013-Present American Society of Transplant Surgeons, grant submission peer review service

COMMITTEE, ORGANIZATIONAL, AND VOLUNTEER SERVICE

2018 North American Sarcopenia Consensus Working Group, American Society of Transplantation 2018 American Society of Transplantation Liver Frailty Working Group 2017-Present Michigan Medicine Quality Council 2017-Present Patient Experience Advisory Council, Michigan Medicine, Physician Liaison 2016-Present AHPBA/ASTS/SSO Consensus Conference Working Group 2016-Present University of Michigan Health System Patient Flow Governance Committee 2016-Present Surgical Lead, University of Michigan Admitting Officer of the Day Program 2016-Present Co-Chair, University of Michigan Operating Room Fire Safety Committee 2016-Present UNOS Joint Societies Working Group on PHS Increased Donor Organs 2016 University of Michigan Department of Surgery Leadership Development Program, Instructor 2016 University of Michigan Health System Change Management Course 2015-Present University of Michigan Department of Surgery Advisory Committee 2015-Present University of Michigan Perioperative Quality Improvement Committee 2015-Present University of Michigan Health System Inpatient Clinical Guideline Steering Committee 2015-Present University of Michigan Health System MiChart Clinical Advisory Committee 2015-Present University of Michigan Health System Patient Placement Decision Making Core Team 2015-Present University of Michigan Health System Population Health Strategy Committee 2015-Present Organ Donation & Transplantation Alliance, Nat’l Critical Issues Forum Planning Committee 2015-Present Medicare Access And CHIP Reauthorization Act (MACRA) Task Force, ASTS 2015-Present Director, Liver Transplant Quality Collaborative (LTQC), www.TransplantQuality.org 2015 Chair, University of Michigan Department of Surgery Incentive Plan Committee 2015-2016 Program Chair, Americas Hepato-Pancreato-Biliary Association Annual Meeting 2015-2016 Program Co-Chair, International Hepato-Pancreato-Biliary Association World Congress, Brazil 2014-2015 Program Co-Chair, Americas Hepato-Pancreato-Biliary Association Annual Meeting 2014-2015 Consensus Conference, ASTS/AHPBA/SSO Hepatobiliary Fellowship Credentials 2014-2016 Education and Training Committee, Americas Hepato-Pancreato-Biliary Association 2013-Present Extended Criteria Liver LEAN team, Gift of Life Michigan Organ Procurement Organization 2013-Present University of Michigan General Surgery Residency Clinical Competency Committee 2013-Present University of Michigan Transplant Ambulatory Care Unit, Advisory Committee 2012-2013 Dissertation Committee, Ludi Fan, Ph.D., University of Michigan School of Public Health 2013 LEAN Enterprise Institute, Partners Workshop, Boston, Massachusetts, July 2013 2012-Present University of Michigan Liver Transplant Executive Committee 2012-Present University of Michigan Transplant Center Executive Committee 2012-Present University of Michigan Liver Transplant Quality Improvement Committee

http://www.transplantquality.org/


2012 Present American Society of Transplant Surgeons Reimbursement and Regulatory Committee 2012-Present Academic Development Committee, University of Michigan Department of Surgery 2012-Present Co-Director, Academic Surgeon Development Program, University of MIchigan 2012-Present Program Committee, Americas Hepato-Pancreato-Biliary Association 2011-Present Clerkship Director for Transplant Surgery, University of Michigan School of Medicine 2011-2013 Leadership Committee, Association for Academic Surgery 2011-2013 Nominating Committee, Association for Academic Surgery 2011-Present Member, Institute for Healthcare Policy and Innovation, University of Michigan 2010-Present Protocol Review Committee, University of Michigan Comprehensive Cancer Center 2010-Present Abdominal Organ Committee, Gift of Life Michigan Organ Procurement Organization 2009-2011 Program Committee, Academic Surgical Congress, Association for Academic Surgery 2009-2010 Program Director, The 2010 Michigan Meeting on Cancer Health Disparities 2001-2005 Education Committee, Johns Hopkins Univ. School of Medicine Dept. of Surgery 1996-1997 President, Council of Class Officers, Vanderbilt University School of Medicine 1995-1997 Barney Brooks Surgical Society, Vanderbilt University School of Medicine 1995-1997 Task Force on Medical Education, Vanderbilt University School of Medicine 1995 Course Director, “Practicing Caring Medicine for AIDS Patients”, Vanderbilt University School

of Medicine

CONSULTING POSITIONS

2000-2002 Consultant, Calypso Medical Inc., Seattle, Washington. 2008-2010 Technical Consultant (unpaid), Ethicon Endo-Surgery. 2011 American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP),

Hepatobiliary Demonstration Project

VISITING PROFESSORSHIPS, SEMINARS, EXTRAMURAL INVITED PRESENTATIONS

1. “Improving outcomes with expanded criteria renal donor grafts”, Invited presentation at the American College of Surgeons 90th Annual Clinical Congress, New Orleans, LA, October 2004.

2. “The Impact of the Economy on Minority Health: A Townhall Meeting”, Invited lecture, Ypsilanti Community Center, Ypsilanti, MI, March 3, 2009.

3. “Surgical Management of Benign Pancreatic Diseases”, Invited Lecture, The University of Michigan Advanced Liver Disease and Liver Transplant Continuing Medical Education Course, Plymouth, MI, May 1, 2009.

4. “Refining the evaluation of candidates for liver transplantation: Frailty, Futility, and Fidelity”, Invited lecture, the Johns Hopkins Comprehensive Transplant Center, Baltimore, MD, September 18, 2009.

5. “The Ethics of Solid Organ Transplantation: Challenges and Lessons for our Healthcare System”, Invited lecture, Eastern Michigan University, Ethics and Healthcare Symposium, Ypsilanti, MI, January 13, 2010. (repeated every semester, 2010-2012)

6. “The Michigan Meeting 2010: The Economy and Cancer Health Disparities”, Program Coordinator, The University of Michigan Rackham School of Graduate Studies, May 20-22, 2010.

7. “The Evolving Multidisciplinary Management of Biliary Tract Malignancies”, Invited Lecture, Synergy Medical Education Alliance, Covenant Hospital, Saginaw, MI, May 27, 2010.

8. "Refining the evaluation of candidates for liver transplantation and high-risk surgical care: Frailty and Morphometry", Surgical Grand Rounds, Indiana University Department of Surgery, November 10, 2010.


9. “Frailty Among Candidates for Liver Transplantation”, Invited Lecture, The University of Michigan Advanced Liver Disease and Liver Transplant Continuing Medical Education Course, Plymouth, MI, May 13, 2011.

10. “Healthcare Disparities 2011: What Can Surgeons Do?, Krishna K. Sahawney Lecture in Biomedical Ethics, Michigan Chapter of the American College of Surgeons, Grand Rapids, MI, May 20, 2011.

11. “Medical and Resident Student Education, Generation Y”, American Society of Transplant Surgeons Winter Symposium, Miami, FL, January 12, 2012.

12. “Restoring the Luster – Stimulating Interest In Transplant Fellowship”, American Society of Transplant Surgeons Winter Symposium, Miami, FL, January 12, 2012.

13. “Frailty Among Candidates for Liver Transplantation”, NIH Workshop on Solid Organ Transplantation in Older Adults, Washington, DC, January 23, 2012.

14. “Surgeon Involvement in Patient Discussion Boards and Blogs”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, January 22, 2013.

15. Panel Discussant, “Survival and Cancer Recurrence in Liver Transplantation for HCC”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, January 23, 2013.

16. Moderator, “Transplantation for NASH”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, January 23, 2013.

17. “Frailty Among Liver Transplant Candidates and Recipients”, Canadian Institutes of Health Research Exercise and Solid Organ Transplant Symposium, Toronto, Ontario, Canada, April 18, 2013.

18. “Frailty Assessment and Interventions in Liver Transplantation”, University of Michigan Advanced Liver Disease and Liver Transplant Continuing Medical Education Course, Novi, MI, May 3, 2013.

19. “Frailty Among Candidates for Liver Transplantation” The Johns Hopkins University School of Medicine Biennial Meeting, Baltimore, Maryland, June 7, 2013.

20. “General Surgery in Patients with Cirrhosis and Portal Hypertension”, Western Michigan Liver Round-Up CME Course, Grand Rapids, Michigan, October 26, 2013.

21. “Hepatobiliary Surgery: Past, Present, and Future”, American Society of Transplant Surgeons Winter Symposium, Miami, Florida, January 24, 2014.

22. “Patient Power: Building a Clinical Program”, Academic Surgical Congress, San Diego, California, January 5, 2014.

23. Moderator, “State of the Art on Islet Cell Transplantation”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, February 21, 2014.

24. Panel Discussant, “Recipient Obesity and Outcomes in Liver Transplantation, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, February 21, 2014.

25. “Liver Transplantation for Neuroendocrine Liver Metastases”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, February 21, 2014.

26. “Organ Donation”, Ask Dr. Nandi Television Program, to air April 1, 2014 27. “General Surgery in Patients with Cirrhosis and Portal Hypertension”, University of Michigan

Advanced Liver Disease and Liver Transplantation CME Course, Novi, Michigan, May 22, 2014. 28. “Medical, Radiological, and Surgical Therapy of HCC”, Western Michigan Liver Round-Up CME

Course, Grand Rapids, MI, October 18, 2014. 29. “Surgical Management of Incidentally Discovered Liver Masses”, American College of Surgeons

Clinical Congress, Surgical Forum, San Francisco, CA, October 28, 2014. 30. Moderator, “Hepatocellular Carcinoma”, American Transplant Congress Pre-Meeting, Philadephia,

PA, May 2, 2015. 31. Moderator, “Cholangiocarcinoma and Neuroendocrine Tumors”, American Transplant Congress Pre-

Meeting, Philadephia, PA, May 2, 2015. 32. “Pursuing Quality in Liver Transplantation: Competition or Collaboration?”, Transplant Grand

Rounds, Mayo Clinic Arizona, Phoenix, AZ, May 14, 2015.


33. “Frailty Among Liver Transplant Candidates and Recipients”, Mississippi Transplant Symposium, University of Mississippi Transplant Center, Jackson, MS, October 15, 2015.

34. “Pursuing Quality in Liver Transplantation: Competition or Collaboration?”, Mississippi Transplant Symposium, University of Mississippi Transplant Center, Jackson, MS, October 15, 2015.

35. “Recipient Selection in Liver Transplantation”, International Hepato-Pancreato-Biliary Association World Congress, Sao Paulo, Brazil, April 21, 2016.

36. “Changes in Allocation for Liver Transplantation: Rationale and Consequences”, University of Michigan Advanced Liver Disease and Liver Transplantation CME Course, Novi, Michigan, May 6, 2016.

37. “Interesting Case Presentations”, Moderator, The Frederick A. Coller Society Annual Meeting, Ann Arbor, MI, September 15, 2016.

38. “How can recipient selection practices facilitate the optimization of organ utilization?”, The Alliance National Critical Issues Forum, Henderson, NV, October 21, 2016.

39. “Liver Transplantation for Hepatic Malignancies”, Brazilian Chapter, International Hepato-Pancreato-Biliary Association, Joao Pessoa, Brazil, February 10, 2017.

40. Moderator, “Updates in Transplantation”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, April 1, 2017.

41. “Machine Preservation in Liver Transplantation”, University of Michigan Advanced Liver Disease and Liver Transplantation CME Course, Novi, Michigan, May 19, 2017.

42. “The Training of the Modern Hepatopancreatobiliary Surgeon”, Invited Speaker, Johns Hopkins University School of Medicine Biennial, Baltimore, Maryland, June 9, 2017.

43. “Culture and Team Building”, University of Michigan Department of Surgery Leadership Development Program, September 22, 2017.

44. “How to Build a Successful Clinical Practice and Add Value to Your System”, Association for Academic Surgery Fall Course 2017, Early Career Development, San Diego, California, October 21, 2017.

45. “PHS Increased Risk Donors: How to Educate Patients, Coordinators & Transplant Centers”, American Association for the Study of Liver Diseases 2017 Liver Meeting, Washington, D.C., October 22, 2017.

46. “Developing and Maintaining a Prehabilitation Program for Liver Transplant Candidates”, American Association for the Study of Liver Diseases 2017 Liver Meeting, Washington, D.C., October 23, 2017.

47. “Surgical Approaches to Pancreatic and Biliary Malignancies”, Western Michigan Liver Round-Up CME Course, Grand Rapids, MI, November 4, 2017.

48. “Hepatocellular Carcinoma, Case Presentations and Discussion”, Moderator, American Society of Transplant Surgeons Winter Symposium, Miami, Florida, January 4, 2018.

49. “Vascular Resection for Hilar Cholangiocarcinoma”, Invited State of the Art Presentation, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, March 9, 2018.

50. “Management of Hepatocellular Carcinoma”, Moderator, ASTS-AHPBA Joint Symposium, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, March 9, 2018.

51. “Living Donation”, Invited panelist, Detroit Minority Organ Tissue Transplant Education Program (MOTTEP), Detroit, Michigan, March 27, 2018.

52. “Updates in Liver Transplantation Allocation and Implications for Donor Selection”, University of Michigan Advanced Liver Disease and Liver Transplantation CME Course, Novi, Michigan, May 11, 2018.

53. “Machine Preservation in Liver Transplantation”, Invited State of the Art Lecture, Association of Organ Procurement Organizations Annual Meeting, Washington, D.C., June 20, 2018.

54. “Professionalism and Leadership”, University of Michigan Department of Surgery Resident Leadership Development Program, June 28, 2018.


55. “An Approach to Liver Masses”, Western Michigan Liver Round-Up CME Course, Grand Rapids, MI, October 13, 2018.

56. “Being a Good Citizen and Leader in Your Institution”, Association for Academic Surgery Fall Course 2018, Early Career Development, Boston, Massachusetts, October 20, 2018.

57. “Creating a Culture of Amplifying and Speaking Out”, Women in Surgery Leadership Development Conference, #HeForShe Track, Michigan Women’s Surgical Collaborative, Ann Arbor, Michigan, November 30, 2018.

58. “Cholangiocarcinoma”, Moderator, American Society of Transplant Surgeons Winter Symposium, Miami, Florida, January 12, 2019.

59. “Bile Duct Injury”, Moderator, ASTS-AHPBA Joint Symposium, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, March 22, 2019.

60. “Immediate Repair of Bile Duct Injury”, Americas Hepato-Pancreato-Biliary Association Annual Meeting, Miami, Florida, March 22, 2019.

61. “Liver Transplantation for Malignancy: Current State and Future Opportunities”, Ascension Michigan GI Conference 2019, ‘Multidisciplinary Management of the GI Cancer Patient”, Troy, Michigan, March 30, 2019.

62. “Hepatocellular Carcinoma: Treatment Options Outside of Transplant”, OptumHealth Education’s " Essentials of Oncology, Solid Organ and Blood/Marrow Transplant Management for the Health Care Team", Scottsdale, Arizona, Aprill 11, 2019.

63. “Updates in Liver Transplantation Allocation and Implications for Donor Selection”, University of Michigan Advanced Liver Disease and Liver Transplantation CME Course, Novi, Michigan, May 3, 2019.

BIBLIOGRAPHY Peer-Reviewed Journals and Publications

1. Eddy VA and the Zone I Penetrating Injury Study Group. Is routine arteriography mandatory for penetrating injury to zone I of the neck? J Trauma 2000;48(2):208-213.

2. Sonnenday CJ, Ratner LE, Zachary AA, Burdick JF, Samaniego MD, Kraus E, Warren DS and

Montgomery RA. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant Proc 2002;34:1614-6.

3. Molmenti EP, Pinto PA, Montgomery RA, Su LM, Kraus E, Cooper M, Sonnenday CJ, Klein AS,

Kavoussi LR and Ratner LE. Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant 2003;3:219-23.

4. Sonnenday CJ, Cooper M, Kraus E, Gage F, Handley C and Montgomery RA. The hazards of basing

acceptance of cadaveric renal allografts on pulsatile perfusion parameters alone. Transplantation 2003;75:2029-33.

5. Sonnenday CJ and Kaufman HS. Use of an implantable marker for rapid intraoperative localization of

nonpalpable tumors: a pilot study in a swine colorectal model. Surg Endosc 2003;17:1927-31.

6. Montgomery RA, Cooper M, Kraus E, Rabb H, Samaniego M, Simpkins CE, Sonnenday CJ, Ugarte RM, Warren DS, and Zachary AA. Renal transplantation at the Johns Hopkins Comprehensive Transplant


Center. Clinical Transplants 2003, Cecka and Terasaki, eds. UCLA Immunogenetics Center, Los Angeles, CA.

7. Warren DS, Zachary AA, Sonnenday CJ, King KE, Cooper M, Ratner LE, Shirey RS, Haas M, Lefell MS,

and Montgomery RA. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 2004;4:561-8.

8. Sonnenday CJ, Warren DS, Cooper M, Saminiego M, Haas M, King KE, Shirey RS, and Montgomery

RA. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004;4:1315-1322.

9. Haas M, Sonnenday CJ, Cicone J, Rabb H, and Montgomery RA. Isometric tubular epithelial

vacuolization in renal allograft biopsies of patients receiving low dose intravenous immunoglobulin for a positive crossmatch. Transplantation 2004;78:549-556.

10. Sonnenday CJ, Warren DS, Cooke SK, Dietz H, and Montgomery RA. A novel chimeric ribozyme

vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium. J Gene Med 2004;6:1394-1402.

11. Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD, Choti MA, Coleman J, Hodgin

MB, Sauter PK, Sonnenday CJ, Wolfgang CL, Marohn MR, and Yeo CJ. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 2006;10:1280-1290.

12. Cohn JA, Englesbe MJ, Ads YM, Paruch J, Pelletier SJ, Welling TH, Sonnenday CJ, Magee JC, Punch JD,

Campbell DA, and Sung RS. Financial implications of pancreas transplant complications: a business case for quality improvement. Am J Transplant 2007;7(6):1656-60.

13. Sonnenday CJ, Dimick JB, Schulick RS, and Choti MA. Racial and Geographic Disparities in the

Utilization of Surgical Therapy for Hepatocellular Cancer. J Gastrointest Surg 2007;11(12):1636-46.

14. Englesbe MJ, Dimick JB, Sonnenday CJ, Share DA, and Campbell DA Jr. The Michigan Surgical Quality Collaborative: Will a Statewide Quality Improvement Initiative Pay for Itself? Ann Surg 2007;246(6):1100-1103.

15. Englesbe MJ, Ads YM, Cohn JA, Sonnenday CJ, Lynch R, Sung RS, Pelletier SJ, Birkmeyer JD, and

Punch JD. The effects of donor and recipient practices on transplant center finances. Am J Transplant 2008;8(3):586-592.

16. Sonnenday CJ and Simeone DM. "Criminal" profiling of the pancreas: when is aggressive therapy

indicated for a non-aggressive entity? Ann Surg 2008;247(4):580-582. 17. Volk ML, Warren GJW, Sonnenday CJ, Marrero JA, and Heisler M. Geographic variation in organ

availability exacerbated disparities in liver transplantation for Hispanics. Amer J Transplant 2009;9(9):2113-2118.

18. Mathur AK, Sonnenday CJ, and Merion RM. Race and ethnicity in access to and outcomes of liver

transplantation: a critical literature review. Amer J Transplant 2009;9(12):2662-2668.


19. Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, Marrero JA, and

Pelletier SJ. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010;16(1):83-90.

20. Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, and Welling TH. Influence of body mass

index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg 2010: 14(5):849-57.

21. Sonnenday CJ. Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Preventable Problem or an Acceptable Risk? Ann Surg Oncol 2010;17(9):2262-2263.

22. Sonnenday CJ, and Birkmeyer JD. A Tale of Two Provinces: Regionalization of Pancreatic Surgery in Ontario and Quebec. Ann Surg Oncol 2010;17(10)2535-2536.

23. Ghaferi AA, Mathur AK, Sonnenday CJ, and Dimick JB. Adverse Outcomes in Patients with Chronic

Liver Disease Undergoing Colorectal Surgery. Ann Surg 2010;252(2)345-350.

24. Englesbe MJ, Patel SP, He K, Lynch RL, Schaubel DE, Harbaugh C, Holcombe SA, Wang SC, Segev DL, and Sonnenday CJ. Sarcopenia and Mortality After Liver Transplantation. J Amer Coll Surg 2010;211(2):271-278.

25. Elmunzer BJ, Boetticher NC, Mobley CM, Brewster ME, and Sonnenday CJ. Iatrogenic Pancreatic Cyst Perforation Successfully Managed by a Minimally Invasive Combined Endoscopic–Laparoscopic Approach. J Laparoendosc Adv Surg Tech 2010;20(8):1-3.

26. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, and Merion RM. Donation after Cardiac Death Liver Transplantation: Predictors of Outcome. Amer J Transpl 2010;10:2512-2519.

27. Hendren S, Banerjee M, Sonnenday CJ, Morris A, and Birkmeyer JD. Surgical Complications are Associated with Omission of Chemotherapy for Stage III Colorectal Cancer. Dis Colon Rectum 2010;53:1587-1593.

28. Mathur AK, Osborne NH, Lynch RL, Ghaferi AA, Dimick JD, and Sonnenday CJ. Racial/ethnic

disparities in access to care and survival for patients with early stage hepatocellular carcinoma. Arch Surg 2010;145(12):1158-1163.

29. Lee DD, Gooden CW, Nadig SN, Sonnenday CJ, Abbott C, Magee JC, Englesbe MJ, Punch JD,

Samaniego M, Merion RM, Sung RS. Living donor kidney transplantation at the University of Michigan. Clin Transpl 2011;77-89.

30. Lee JS, He K, Harbaugh CM, Schaubel DE, Sonnenday CJ, Wang SC, Englesbe MJ, and Eliason JL. Frailty, Core Muscle Size, and Mortality in Patients Undergoing Open Abdominal Aortic Aneurysm Repair. J Vasc Surg 2011;53(4):912-917.

31. Jorgensen JE, Waljee AK, Volk ML, Sonnenday CJ, Elta GH, Al-Hawary MM, Singal AG, Taylor JR, and Elmunzer BJ. Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis. Gastrointest Endosc 2011;73(5):955-962.


32. Elmunzer BJ, Sonnenday CJ, Taylor JR, Furlan JP, Schomisch SJ, Scheiman JM, Chak A, Marks JM, and

Ponsky JL. Endoscopic access to and exploration of the lesser sac in a human cadaver model: opportunity for transgastric endoscopic pancreatic surgery (with video). Surg Endosc 2011;25(8):2725-2730.

33. Harbaugh C, Afana M, Burdick S, East J, Kodali S, Lee J, Patel S, Rangrass G, Ranney D, Sood V, Lynch R, Sonnenday CJ, Englesbe MJ, and Mathur AK. Portrayal of Organ Donation and Transplantation on American Primetime Television. Clin Transplantation 2011;213(2):236-244.

34. Lee JS, Terjimanian MN, Tishberg LM, Alawieh AZ, Harbaugh CM, Sheetz KH, Holcombe SA, Wang SC,

Sonnenday CJ, and Englesbe MJ. Surgical Site Infection and Analytic Morphometric Assessment of Body Composition in Patients Undergoing Midline Laparotomy. J Am Coll Surg 2011213(2):236-244.

35. Frischmeyer-Guerrerio PA, Montgomery RA, Cooke SK, Sonnenday CJ, Warren DS, Geurrerio AL, and Dietz HC. TCRbeta mRNA-Mediated Perturbation of Thymocyte Development in Nonsense Mediated Decay-Deficient Mice. Proc Natl Acad Sci USA 2011;108(26):10638-10643.

36. Garonzik-Wang JM, Govindan P, Grinnan JW, Liu M, Ali HM, Chakraborty A, Jain V, Ros RL, James NT, Kucirka LM, Hall EC, Berger JC, Montgomery RA, Desai NM, Dagher NN, Sonnenday CJ, Englesbe MJ, Makary MA, Walston JD, Segev DL. Frailty and delayed graft function in kidney transplant recipients. Arch Surg 2012;147(2):190-193.

37. Waits SA, Reames BN, Englesbe MJ, Lee DD, Punch JD, Pagani FD, and Sonnenday CJ. There is plenty for everyone: transection of the infracardiac inferior vena cava during organ recovery. Liver Transpl 2012;18(4):490-2.

38. Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM,

Sonnenday CJ, Abrams R, Leslie W, Khan G, Zalupski MM. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2012;84(5):1166-1171.

39. Englesbe MJ, Lee JS, He K, Fan L, Schaubel DE, Sheetz KH, Harbaugh CM, Holcombe SA, Campbell DA Jr, Sonnenday CJ, and Wang SC. Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg 2012;256(2):255-261.

40. Elmunzer BJ, Debenedet A, Volk ML, Sonnenday CJ, Waljee A, Fontana R, Oza A, Singal A, Englesbe MJ, and Scheiman J. Clinical yield of diagnostic ERCP in orthotopic liver transplant recipients with suspected biliary complications. Liver Transpl 2012;18(12):1479-1484.

41. Wahl WL, Wong SL, Sonnenday CJ, Hemmila MR, Dimick JB, Flanders SA, Desmond JS, Bahl V, and Henke PK. Implementation of a small bowel obstruction guideline improves hospital efficiency. Surgery 2012;152:626-634.

42. Revels SJ, Banerjee M, Yin H, Sonnenday CJ, and Birkmeyer JD. Racial disparities in surgical resection

and survival among elderly patients with poor prognosis cancer. J Am Coll Surg 2013;216(2):312-319.


43. Englesbe MJ, Terjimanian MN, Lee JS, Sheetz KH, Harbaugh CM, Hussain A, Holcombe SA, Sullivan J, Campbell DA Jr, Wang SC, Sonnenday CJ. Morphometric age and surgical risk. J Am Coll Surg 2013;216(5):976-985.

44. Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, and Malani PN. Association

between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013;19(12):1936-1402.

45. Welling TH, Feng M, Wan S, Hwang SY, Volk ML, Lawrence TS, Zalupski MM, and Sonnenday CJ.

Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl 2014;20(1):81-88.

46. Waits SA, Kim EK, Terjimanian MN, Tishberg LM, Harbaugh CM, Sheetz KH, Sonnenday CJ, Sullivan J,

Wang SC, Englesbe MJ. Morphometric Age and Mortality After Liver Transplant. JAMA Surg 2014;149(4):335-340.

47. Lee CS, Cron DC, Terjimanian MN, Canvasser LD, Mazurek AA, Vonfoerster E, Tishberg LM,

Underwood PW, Chang ET, Wang SC, Sonnenday CJ, and Englesbe MJ. Dorsal muscle group and surgical outcomes in liver transplantation. Clin Transplant 2014;28(10):1092-1098.

48. Mathur S, Janaudis-Ferreira T, Wickerson L, Singer LG, Patcai J, Rozenberg D, Blydt-Hansen T,

Hartmann EL, Haykowsky M, Helm D, High K, Howes N, Kamath BM, Lands L, Marzolini S, and Sonnenday C. Meeting Report: Consensus Recommendations for a Research Agenda in Exercise in Solid Organ Transplantation. Am J Transplant 2014;14(10):2235-2245.

49. Derck JE, Thelen AE, Cron DC, Friedman JF, Gerebics AD, Englesbe MJ, and Sonnenday CJ. Quality of

Life in Liver Transplant Candidates: Frailty Is a Better Indicator Than Severity of Liver Disease. Transplantation 2015;99(2):340-344.

50. Mathur AK, Nadig SN, Kingman S, Lee D, Kinkade K, Sonnenday CJ, and Welling TH. Internal biliary

stenting during orthotopic liver transplantation: anastomotic complications, post-transplant biliary interventions, and survival. Clin Transplant 2015(4):327-335.

51. Volk ML, Goodrich N, Lai JC, Sonnenday C, and Shedden K. Decision Support for Organ Offers in Liver

Transplantation. Liver Transpl 2015;21(6):784-791.

52. Yu J, Hosmer A, Parks T, Sonnenday CJ, and Sharma P. Predictors of Early Hospitalization After Deceased Donor Liver Transplantation. Dig Dis Sci 2015;60(11):3242-3247.

53. Terjimanian MN, Harbaugh CM, Hussain A, Olugbade Jr KO, Waits SA, Wang SC, Sonnenday CJ,

Englesbe MJ. Abdominal Adiposity, Body Composition, and Survival after Liver Transplantation. Clin Transplant 2016;30(3):289-294.

54. Cron DC, Friedman, JF, Winder, GS, Thelen AE, Derck JE, Fakhoury JW, Gerebics AD, Englesbe MJ,

and Sonnenday CJ. Depression and Frailty in Patients with End-Stage Liver Disease Referred for Transplant Evaluation. Am J Transplant 2016;16(6):1805-1811.


55. Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, Wang SC, and Su GL. Bone Mineral Density Predicts Post-transplant Survival among Hepatocellular Carcinoma Liver Transplant Recipients. Liver Transpl 2016;22(8):1092-1098.

56. Konerman MA, Fritze D, Weinberg RL, Sonnenday CJ, and Sharma P. Incidence and Risk Assessment

for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review. Transplantation 2017;101(7)1645-1657.

57. Parikh ND, Marrero WJ, Sonnenday CJ, Lok AS, Hutton DW, and Lavieri MS. Population-Based

Analysis and Projections of Liver Supply Under Redistricting. Transplantation. 2017 Sep;101(9):2048-2055.

58. Hsu EK, Shaffer ML, Gao L, Sonnenday C, Volk ML, Bucuvalas J, Lai JC. Analysis of Liver Offers to

Pediatric Candidates on the Transplant Wait List. Gastroenterology 2017; Oct;153(4):988-995.

59. Kamarajah SK, Frankel TL, Sonnenday C, Cho CS, and Nathan H. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis. J Surg Oncol 2018;117(4):644-650.

60. Lurz E, Quammie C, Englesbe M, Alonso EM, Lin HC, Hsu EK, Furuya KN, Gupta NA, Venkat VL, Daniel JF, Leonis MA, Miloh T, Telega GW, Yap J, Menendez J, Book LS, Himes RW, Sundaram SS, Parekh R, Sonnenday C, Bucuvalas J, Ng VL, Kamath BM. Frailty in Children with Liver Disease: A Prospective Multicenter Study. J Pediatr 2018;194:109-115.

61. Tapper EB, Konerman M, Murphy S, Sonnenday CJ. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant 2018 Oct;18(10):2566-2570.

62. Park JM, Koerschner C, Mawby J, Selman S, Kwon HK, Sonnenday CJ, Wright Nunes JA, Sharma P. Knowledge of chronic kidney disease among liver transplant recipients. Liver Transpl 2018 Sep;24(9):1288-1292.

63. Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E, Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, and Lai JC. Report from the American Society of Transplantation on Frailty in Solid Organ Transplantation. Am J Transplant 2019 Apr;19(4):984-994.

64. Kamarajah SK, Sonnenday CJ, Cho CS, Frankel TL, Bednar F, Lawrence TS, and Nathan H. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis. Ann Surg 2019 Feb 25. doi: 10.1097/SLA.0000000000003242. [Epub ahead of print].

65. Barrett M, Holt K, Haley A, Leininger L, Sonnenday CJ, Sandhu G, and Gauger PG. Needs assessment can guide creation of a "resident-optimized clinic" in surgery. Am J Surg 2019 Feb 12. pii: S0002-9610(18)31218-2. doi: 10.1016/j.amjsurg.2019.02.005. [Epub ahead of print].

https://www.ncbi.nlm.nih.gov/pubmed/28945663






66. Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant 2019 Apr 13. doi: 10.1111/ajt.15392. [Epub ahead of print].

67. Likhitsup A, Hassan A, Mellinger J, Askari F, Winder GS, Saeed N, Sonnenday CJ, Sharma P, and Fontana RJ. A prohibitive tobacco use policy does not reduce the proportion of smokers listed for liver transplantation. Liver Transpl 2019 May 22. Doi:10.1002/lt.25497. [Epub ahead of print]

68. Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, and Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019 Jun 20. doi: 10.1002.

69. McElroy LM, Likhitsup A, Winder GS, Saeed N, Hassan A, Sonnenday CJ, Fontana RJ, and Mellinger J. Gender Disparities in Patients with Alcoholic Liver Disease Evaluated for Liver Transplantation. Transplantation 2019 Jun 24. doi: 10.1097

70. Paul J Grant, MD, Anthony J Courey, MD, Sarah Hanigan, PharmD, Mark S Kolbe, MD, Steven L Kronick, MD, Andrea Obi, MD, F Jacob Seagull, PhD, Suman L Sood, MD, Thomas W Wakefield, MD, David M Williams, MD, James B Froehlich, MD, Robert Fontana, MD, Jonathan W Haft, MD, and Sonnenday CJ, MD. Special Topics in Venous Thromboembolism [Internet]. Ann Arbor (MI): Michigan Medicine University of Michigan; 2019 Feb. Available from https://www.ncbi.nlm.nih.gov/books/NBK544377/. PubMed PMID: 31339682 and from UMHS at http://www.uofmhealth.org/provider/clinical-care-guidelines]

71. Leek RB, Park JM, Koerschner C, Mawby J, Sonnenday CJ, Wright Nunes JA, and Sharma P. Novel educational and goal-setting tool to improve knowledge of chronic kidney disease among liver transplant recipients: A pilot study. PLoS One 2019 Jul 25;14(7):e0219856.

72. Saeed N, Glass L, Sharma P, Shannon C, Sonnenday CJ, and Tincopa MA. Incidence and Risks for Non Alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Review and Meta-analysis. Transplantation 2019 Aug 12. doi: 10.1097.

73. McElroy L, Likhitsup A, Sabeed N, Hassan A, Winder GS, Sonnenday C, Fontana R, Mellinger J. Re: Distinguishing between Sex and Gender is Critical for Research in Transplantation. Transplantation 2019 Sep 3. doi: 10.1097.

74. Tran NH, Sahai V, Griffith KA, Nathan H, Kaza R, Cuneo KC, Shi J, Kim E, Sonnenday CJ, Cho CS, Lawrence TS, Zalupski MM. Phase II trial of neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2019 Sep 5. pii: S0360-3016(19)33746-0. doi: 10.1016.

Book Chapters

1. Sonnenday CJ, Lillemoe KD, and Yeo CJ. Pseudocysts and other complications of chronic pancreatitis. Shackleford’s Surgery of the Alimentary Tract (ninth edition) 2001. W. B. Saunders Company.

http://www.uofmhealth.org/provider/clinical-care-guidelines


2. Sonnenday CJ and Kaufman HS. Diverticulitis. The Practice of General Surgery 2001. W.B. Saunders Company.

3. Sonnenday CJ and Yeo CJ. Open gastrojejunostomy. Operative Techniques in General Surgery:

Gastric Surgery for Benign Disease June 2003. W.B. Saunders Company. 4. Sonnenday CJ and Zeiger MA. Adrenal Incidentaloma. Surgical Decision Making (fifth edition) 2004.

W.B. Saunders Company. 5. Sonnenday CJ, Marohn M, and Yeo CJ. Cystic neoplasms of the pancreas. Maingot’s Abdominal

Operations (11th edition) 2005. McGraw-Hill Medical Publishing, New York, NY. 6. Sonnenday CJ. Liver Trauma. Current Surgical Therapy (Ninth edition) 2007. Mosby Publishing,

Philadelphia, PA.

7. Sonnenday CJ. Foreword & Content Editor. The Johns Hopkins A.B.S.I.T.E. Review Manual (First edition) 2008. Lippincott, Williams and Wilkins, Philadelphia, PA.

8. Sonnenday CJ, Pelletier SJ, and Welling TH. Hepatic neoplasms. Greenfield’s Surgery: Scientific

Principles and Practice (5th edition) 2010. Lippincott, Williams, & Wilkins, Philadelphia, PA.

9. Sonnenday CJ. Complications of Biliary Surgery. Complications in Surgery (2nd edition) 2010. Lippincott, Williams, & Wilkins, Philadelphia, PA.

10. Sonnenday CJ. Bile Duct Injury. Clinical Scenarios in Surgery (first edition) 2012. Lippincott, Williams and Wilkins, Philadelphia, PA.

11. Sonnenday CJ. Liver Mass in Chronic Liver Disease. Clinical Scenarios in Surgery (first edition) 2012. Lippincott, Williams and Wilkins, Philadelphia, PA.

12. Frankel TL and Sonnenday CJ. Obstructive Jaundice. Clinical Scenarios in Surgery (first edition) 2012. Lippincott, Williams and Wilkins, Philadelphia, PA.

13. Sonnenday CJ. Liver Transplantation Using a Cavocavostomy. Operative Techniques in

Transplantation Surgery (first edition) 2015. Wolters Kluwer Health, Philadelphia, PA.

14. Sonnenday CJ, Liver Transplant in Clinical Decision Support: Surgery, edited by Lillemoe K, de Moya M, House M, Hutter M. 2016. Decision Support in Medicine, LLC. Wilmington, DE.

15. Sonnenday CJ, Liver Transplantation for Hepatocellular Carcinoma: The Challenge of Organ Availability, in Primary and Metastatic Liver Tumors: Treatment Strategy and Evolving Therapies, edited by Cardona K and Maithel SK. 2018. Springer Publishing Company, New York, NY.

16. Winslow ER and Sonnenday CJ. Bile Duct Injury. Clinical Scenarios in Surgery (second edition) 2018. Lippincott, Williams and Wilkins, Philadelphia, PA.

17. Navarez N and Sonnenday CJ. Liver Mass in Chronic Liver Disease. Clinical Scenarios in Surgery (second edition) 2018. Lippincott, Williams and Wilkins, Philadelphia, PA.


Books

1. Chen H and Sonnenday CJ, eds. Manual of Common Bedside Surgical Procedures (second edition) 2000. Lippincott, Williams and Wilkins, Philadelphia, PA.

2. Dimick JB, Upchurch Jr GB, and Sonnenday CJ, eds. Clinical Scenarios in Surgery (first edition) 2012. Lippincott, Williams and Wilkins, Philadelphia, PA.

3. Dimick JB, Upchurch Jr GB, Sonnenday CJ, and Kao L, eds. Clinical Scenarios in Surgery (2nd edition) 2018. Lippincott, Williams and Wilkins, Philadelphia, PA.

Other Media

1. Educational video: Sonnenday CJ, Englesbe MJ, Mathur AK, Heidt D, Magee JC, Punch JD, Sung RS, Welling TH, Woodside KJ, and Pelletier SJ. “Side-to-Side Cavocavostomy: An easier anastomosis with improved outcomes.” http://www.youtube.com/watch?v=1xVsO9MyRC4&feature=youtu.be, >250 views.

2. Audio digest: Sonnenday CJ. “Recognition and Treatment of Frailty Among Candidates for Liver Transplantation”. Audio Digest Gastroenterology 2014;28(16): August 21, 2014.

3. Audio digest: Sonnenday CJ. “Hepatocellular Carcinoma” Audio Digest Gastroenterology 2015;29(7):

April 7, 2015. Selected Abstracts

1. Sonnenday CJ, Cooke SK, Warren DS, Dietz H, and Montgomery RA. An in situ expressed chimeric antisense vector inhibits ICAM-1 expression on vascular endothelium. (Platform presentation at the Society of University Surgeons 62nd Annual Meeting, Resident’s Section, Chicago, February 2001).

2. Sonnenday CJ, Cooke SK, Warren DS, Dietz H, and Montgomery RA. U1snRNA / ribozyme chimeric

vectors as a novel vehicle for the delivery of in situ expressed regulatory molecules. (Vector targeting strategies for gene therapy, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, March 2001).

3. Sonnenday CJ, Cooke SK, Warren DS, Dietz H, Ratner LR, and Montgomery RA. A novel strategy for

interrogating the function of individual genes in the ischemia / reperfusion injury pathway. (Platform presentation at the International Conference on Transplantation, Nagoya, Japan, July 2001).

4. Sonnenday CJ, Zachary AA, Ratner LE, Burdick JF, Saminiego M, Kraus E, Warren DS, and

Montgomery RA. Pre-emptive therapy with plasmapheresis / intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive crossmatch. (Platform

http://www.youtube.com/watch?v=1xVsO9MyRC4&feature=youtu.be


presentation and winner of the Young Investigator’s Award at the 2nd International Congress on Immunosuppression, San Diego, CA, December 2001).

5. Sonnenday CJ and Montgomery RA. Use of plasmapheresis and intravenous immunoglobulin to

allow transplantation across immunologic barriers. (Resident Research Award winner, Baltimore Academy of Surgery, February 2002).

6. Sonnenday CJ, Kraus E, Gage FA, Ratner LE, Burdick JF, and Montgomery RA. Cadaveric kidneys

from extended criteria donors treated with pulsatile perfusion have durable long-term function comparable to kidneys from ideal donors. (Henry Christian Award winner, Presented at the American Federation for Medical Research Clinical Research Meeting, April 2002).

7. Sonnenday CJ, Kraus E, Gage FA, Ratner LE, Burdick JF, and Montgomery RA. Cadaveric kidneys

from extended criteria donors treated with pulsatile perfusion have durable long-term function comparable to kidneys from ideal donors. (Presented at the American Transplant Congress, Washington, D.C., April 2002).

8. Montgomery RA, Samaniego MD, Zachary AA, Sonnenday CJ, Warren DS, Molmenti EP, and Ratner

LE. Differing patterns of antibody suppression and re-emergence between ABO incompatible and positive crossmatch kidney transplants. (Presented at the American Transplant Congress, Washington, D.C., April 2002).

9. Sonnenday CJ, Ratner LE, Samaniego MD, Zachary AA, King KE, Racusen LC, Warren DS, and

Montgomery RA. Rescue therapy with plasmapheresis and intravenous immunoglobulin successfully treats acute humoral rejection following renal transplantation. (Presented at the American Transplant Congress, Washington, D.C., April 2002).

10. Sonnenday CJ, Warren DS, Cooke SK, Dietz H, and Montgomery RA. A novel chimeric ribozyme

vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium. (George Zuidema Basic Science Research Award winner, presented at the Johns Hopkins Department of Surgery Grand Rounds, May 2002).

11. Montgomery RA, Sonnenday CJ, Kraus E, Gage FA, and Burdick JF. Pulsatile perfusion protects

extended criteria cadaveric kidneys from graft loss. (Presented at the XIX International Congress of the Transplantation Society, Miami, Florida, August 2002).

12. Montgomery RA, Sonnenday CJ, Saminiego MD, Zachary AA, Warren DS, and Ratner LE. Antibody

suppression and re-emergence in positive crossmatch and ABO incompatible kidney transplant recipients. (Presented at the XIX International Congress of the Transplantation Society, Miami, Florida, August 2002).

13. Warren DS, Sonnenday CJ, Cooke SK, and Montgomery RA. Protecting allografts from ischemia /

reperfusion injury: novel strategies to inactivate the ICAM-1 gene in endothelial cells. (Presented at the XIX International Congress of the Transplantation Society, Miami, Florida, August 2002).

14. Sonnenday CJ, Cooper M, Gage FA, Kraus E, Montgomery RA. The hazards of basing acceptance of

cadaveric renal allografts on pulsatile perfusion parameters alone. (Presented at the XIX International Congress of the Transplantation Society, Miami, Florida, August 2002).


15. Sonnenday CJ, Ratner LE, Saminiego MD, Zachary AA, King KE, Racusen LC, Warren DS, and

Montgomery RA. Durable graft function and donor-specific antibody suppression following live donor renal transplantation in patients treated with pre-emptive plasmapheresis / intravenous immunoglobulin. (Presented at the XIX International Congress of the Transplantation Society, Miami, Florida, August 2002).

16. Sonnenday CJ, Warren DS, Cooke SK, Simpkins C, Dietz H, and Montgomery RA. A novel chimeric

ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium. (Presented at the Society of University Surgeons, Houston, TX, February 2003).

17. Sonnenday CJ and Kaufman HS. Use of an implantable marker for rapid intraoperative localization

of nonpalpable tumors: a pilot study in a swine colorectal model. (Presented at SAGES, Los Angeles, CA, March 2003).

18. Sonnenday CJ, Warren DS, Zachary AA, King KE, Cooper M, Haas M, and Montgomery RA. Renal

transplantation in patients who have both a positive crossmatch and ABO incompatibility with their live donor. (Presented at the American Transplant Congress, Washington, D.C., April 2003).

19. Sonnenday CJ, Graziani J, Zachary AA, King KE, Haas M, Samaniego M, and Montgomery RA.

Characterization of acute rejection episodes following pre-emptive plasmapheresis / CMVIg to abrogate a positive crossmatch and allow live donor renal transplantation. (Presented at the American Transplant Congress, Washington, D.C., April 2003).

20. Jacobbi LM, Gage F, Montgomery RA, and Sonnenday CJ. Machine preservation improves functional

outcomes in cadaveric renal transplantation. (Presented at the American Transplant Congress, Washington, D.C., April 2003).

21. Racusen LC, Montgomery RA, Samaniego M, Sonnenday CJ, Zachary AA, Kraus E, and Haas M.

Biopsy findings in sensitized patients receiving renal transplant after pre-emptive plasmapheresis / CMVIg. (Presented at the American Transplant Congress, Washington, D.C., April 2003).

22. Sonnenday CJ, Merlo CA, Aberegg SK, Hager D, and Goodman S. Do pulmonary artery catheters

affect mortality in critically ill patients? A systematic review of randomized clinical trials and cohort studies. (Upjohn Clinical Research Award winner, presented at the Johns Hopkins Department of Surgery Grand Rounds, May 2003).

23. Sonnenday CJ, Dimick JB, Schulick RD, and Choti MA. Racial and geographic disparities in the

performance of hepatectomy for primary hepatic malignancies. (Presented at the Association of Academic Surgery, Sacramento, CA, November 2003).

24. Simpkins CE, Warren DS, Sonnenday CJ, Cooper M, King KE, Haas M, and Montgomery RA.

Accommodation of ABO incompatible renal allografts is associated with persistent C4d staining. (Presented at the American Transplant Congress, Boston, MA, May 2004).

25. Warren DS, Sonnenday CJ, Cooper M, Simpkins CE, King KE, Shirey S, Samaniego M, and

Montgomery RA. ABO incompatible transplantation using anti-CD20 without splenectomy.


(Presented at the 20th Annual International Congress of the Transplantation Society, Vienna, Austria, September 2004).

26. Simpkins CE, Sonnenday CJ, Warren DS, Segev D, Zachary AA, Cooper M, Haas M, King KE, Ratner LE,

Collins V, and Montgomery RA. Plasmapheresis/CMVIg rescue therapy for acute antibody-mediated rejection in kidney transplant recipients. (Presented at the 20th Annual International Congress of the Transplantation Society, Vienna, Austria, September 2004).

27. Montgomery RA, Simpkins CE, Warren DS, King KE, Sonnenday CJ, Cooper M, Collins V, and Ratner

LE. High titer ABO incompatible kidney transplantation from A1 donors. (Presented at the 20th Annual International Congress of the Transplantation Society, Vienna, Austria, September 2004).

28. Warren DS, Simpkins CE, Zachary AA, Cooper M, Sonnenday CJ, King KE, Leffell MS, Collins V, and

Montgomery RA. Results of kidney transplantation at the time of a positive cytotoxic crossmatch. (Presented at the 20th Annual International Congress of the Transplantation Society, Vienna, Austria, September 2004).

29. Simpkins CE, Warren DS, Sonnenday CJ, Zachary AA, Cooper M, Lees L, Ratner LE, and Montgomery

RA. Improved results with selective use of splenectomy and anti-CD20 for positive crossmatch transplants. (Presented at the 20th Annual International Congress of the Transplantation Society, Vienna, Austria, September 2004).

30. Sonnenday CJ. Surgical residency training in the 21st century: generalization vs. specialization.

(Presented at the Johns Hopkins Department of Surgery Grand Rounds, November 2004). 31. Sonnenday CJ, Berman L, Winter J, Riall TS, Cameron JL, and Yeo CJ. Characterization of Pre-

Operative Risk Factors Associated with Complications Following Pancreaticoduodenectomy. (Presented at the 39th annual meeting of the Pancreas Club, Chicago, IL, May 2005).

32. Sonnenday CJ, Warren DS, Collins V, Locke J, Simpkins CE, Kraus ES, Haas M, Baldwin III WM, Kickler

TS, Rabb H, and Montgomery RA. Routine Pulsatile Perfusion Does Not Improve Early Outcomes of Expanded Criteria Donor Kidneys: Results of a Prospective Trial. (Presented at the American Transplant Congress 2007, San Francisco, CA, May 2007).

33. Sonnenday CJ, Dimick JB, Schulick RS, and Choti MA. Racial and Geographic Disparities in the

Utilization of Surgical Therapy for Hepatocellular Cancer. (Presented at the Society for Surgery of the Alimentary Tract Presidential Plenary Session, Digestive Disease Week 2007, Washington, D.C., May 2007).

34. Englesbe MJ, Muhammad W, Ranney D, Al-Holou S, Kubus J, Sonnenday CJ, Welling T, Punch JD, and

Pelletier SJ. Are Patients with Portal Vein Thrombosis High-Risk Liver Transplant Candidates? (Presented at the ASTS 8th Annual State of the Art Winter Symposium, Marco Island,, FL, January 2008).

35. Welling TH, Heidt DG, Ammori JB, Englesbe MJ, Sonnenday CJ, and Pelletier SJ. Basiliximab Induction

Increases Postoperative Infection Rates with No Change in HCV Recurrence in Liver Transplant Patients at Risk for Renal Insufficiency. (Presented at the ASTS 8th Annual State of the Art Winter Symposium, Marco Island, FL, January 2008).


36. Sonnenday CJ, Kubus J, and Englesbe MJ. The Trivial Impact of the MELD Allocation System on Racial

Disparities Among Candidates for Liver Transplantation. (Presented at The University of Colorado Controversies in Transplantation conference, Breckenridge, CO, March 2008).

37. Sonnenday CJ, Guidinger MK, and Merion RM. Death, Transplant, And Recovery Without Transplant

Among Candidates With Acute Liver Failure (ALF) On The Transplant Waiting List. (Presented at the American Transplant Congress, Toronto, Ontario, Canada, June 2008).

38. Sonnenday CJ, Kubus J, Mathur AK, Englesbe MJ, and Merion RM. Race/Ethnicity and Geographic

Disparities in Waitlisting and Waitlist Outcomes in the Post-MELD Era. (Presented at the 59th Annual Meeting of the American Association for the Study of Liver Disease (AASLD), San Francisco, CA, November, 2008).

39. Mobley C, Welling TH, Sonnenday CJ, Englesbe MJ, Marrero JA, and Pelletier SJ. The Effect of

Locoregional Therapy for Hepatocellular Carcinoma prior to Liver Transplantation. (Presented at the 59th Annual Meeting of the American Association for the Study of Liver Disease (AASLD), San Francisco, CA, November, 2008).

40. Sonnenday CJ, Lewin S, Magee JC, Merion RM, Punch JD, Pelletier SJ, Sung RS, Welling TW, and

Englesbe MJ. Is the Right Kidney Ever Really Wrong? Comparison of Early and Late Graft Outcomes in the Open and Laparoscopic Donor Nephrectomy Eras. (Presented at the 2009 Annual Winter Meeting of the American Society of Transplant Surgeons, Marco Island, FL, January 2009).

41. Sonnenday CJ, Kubus J, Mathur AK, Englesbe MJ, and Merion RM. Race/Ethnicity and Geographic

Disparities among Liver Transplant Candidates: Has MELD-Based Allocation Helped? (Presented at the 2009 Academic Surgical Congress, Fort Meyers, FL, February 2009).

42. Sonnenday CJ, Englesbe MJ, Mathur AK, Magee J, Punch JD, Sung RS, Welling TH, and Pelletier SJ.

Side-to-side cavocavostomy: An easier anastomosis associated with improved transplant outcomes. (Video and poster presentation at the International Liver Transplant Society, New York, NY, June 2009).

43. Patel SP, He K, Lynch RJ, Schaubel DE, Al-Holou SN, Lewin SA, Ranney DN, Holcombe SA, Wang SC,

Sonnenday CJ, Englesbe MJ. Central Sarcopenia and Post-Liver Transplant Mortality. (Presented at the A. Alfred Taubman Medical Research Institute's 2009 Symposium, Ann Arbor, MI. October, 2009).


Sonnenday CJ, Englesbe MJ. Central Sarcopenia and Post-Liver Transplant Mortality. (Presented at the American College of Surgeons 95th Annual Clinical Congress, Chicago, IL. October, 2009).


Sonnenday CJ, Englesbe MJ. Central Sarcopenia and Post-Liver Transplant Mortality. (Presented at the American Society of Transplant Surgeons 10th Annual State of the Art Winter Symposium, Fort Lauderdale, FL. January, 2010).


46. Sonnenday CJ, Harris ME, Lewin SA, and Englesbe MJ. Moving Beyond MELD: Measuring Frailty in Patients Evaluated for Liver Transplantation. (Presented at the American Society of Transplant Surgeons 10th Annual State of the Art Winter Symposium, Fort Lauderdale, FL. January, 2010).

47. Lewin SA, Harris ME, Englesbe MJ, and Sonnenday CJ. Measuring Frailty in Patients Evaluated for

Liver Transplantation. (Presented at the 5th Annual Academic Surgical Congress, San Antonio, TX. February, 2010).

48. Ghaferi AA, Mathur AK, Sonnenday CJ, and Dimick JB. Adverse Outcomes in Patients with Chronic

Liver Disease Undergoing Colorectal Surgery. (Presented at the 5th Annual Academic Surgical Congress, San Antonio, TX. February, 2010).

49. Lee JS, Patel SP, Harbaugh CM, Wang SC, Sonnenday CJ, Eliason JL, Englesbe MJ. Frailty, Core Muscle Size, and Post-Operative Mortality. (Presented at the Frederick A. Coller Society 56th Clinical Meeting. Ann Arbor, MI. September, 2010).

50. Harbaugh C, Afana M, Burdick S, East J, Kodali S, Lee J, Patel S, Rangrass G, Ranney D, Sood V, Lynch R, Sonnenday CJ, Englesbe MJ, and Mathur AK. Portrayal of Organ Donation and Transplantation onAmerican Primetime Television. (Presented at the American College of Surgeons 96th Annual Clinical Congress , Washington, DC, October, 2010).

51. Harbaugh CM, Afana MM, Burdick SM, East JR, Kodali S, Lee JS, Patel SP, Rangrass G, Ranney DN, Sood V, Lynch RJ, Sonnenday CJ, Englesbe MJ, and Mathur AK. Portrayal of Organ Donation and Transplantation in American Primetime Television. (Poster presentation at 145th Michigan State Medical Society Annual Scientific Meeting. Troy, MI. October 2010).

52. Sonnenday CJ, Volk ML, and Englesbe MJ. Moving Beyond MELD: Frailty Predicts Survival Among Candidates for Liver Transplantation. (Plenary presentation at the 61st American Association for the Study of Liver Diseases Annual Liver Meeting, Boston, MA, October 2010).

53. Roberts AN, Harris ME, Harbaugh CM, Friedman JF, Lahidji SA, Englesbe MJ, and Sonnenday CJ. Frailty among Candidates for Liver Transplantation: A Independent Domain Associated with Decreased Survival and Quality of Life. (Plenary presentation at the American Society of Transplant Surgeons 11th Annual State-of-the-Art Winter Symposium, Hollywood, FL, January 2011).

54. Harbaugh CM, Afana MM, Burdick SM, East JR, Kodali S, Lee JS, Patel SP, Rangrass G, Ranney DN, Sood V, Lynch RJ, Sonnenday CJ, Englesbe MJ, Mathur AK. Portrayal of Organ Donation and Transplantation in American Primetime Television. (Poster presentation at the American Society of Transplant Surgeons 11th Annual State-of-the-Art Winter Symposium, Hollywood, FL, January 2011).

55. Harris ME, Harbaugh CM, Friedman JF, Lahidji SA, Roberts AN, Englesbe MJ, and Sonnenday CJ. Frailty In Patients Referred For Liver Transplant Evaluation: An Independent Domain Associated With Decreased Survival. (Plenary presentation at the 6th Annual Academic Surgical Congress, Huntington Beach, CA, February 2011).

56. Lee JS, Harbaugh CM, Terjimanian MN, Tishberg LM, Alawieh AZ, Kowalsky DB, Holcombe SA, Wang

SC, Sonnenday CJ, Englesbe MJ. Abdominal Aorta Calcification in Surgical Patients. Journal of Surgical Research. February 2011. 165(2);332.


57. Sheetz KH, Lee JS, Terjimanian MN, Alawieh AZ, Harbaugh CM, Tishberg LM, Kowalsky DB, Holcombe

SA, Wang SC, Sonnenday CJ, Englesbe MJ. Core Muscle Size as an Independent Domain of Preoperative Risk. Journal of Surgical Research. February 2011. 165(2); 332.

58. Harbaugh CM, Lee JS, Terjimanian MN, Tishberg LM, Alawieh AZ, Kowalsky DB, Holcombe SA, Wang

SC, Sonnenday CJ, Englesbe MJ. Abdominal Aorta Calcification in Surgical Patients. Poster session. University of Michigan Department of Surgery 23rd Annual Moses Gunn Research Conference. Ann Arbor, MI. May 12, 2011.

59. Harbaugh CM, Afana MM, Burdick SM, East JR, Kodali S, Lee JS, Patel SP, Rangrass G, Ranney DN,

Sood V, Lynch RJ, Sonnenday CJ, Englesbe MJ, Mathur AK. Portrayal of Organ Donation and Transplantation on American Primetime Television. Poster session. University of Michigan Department of Surgery 23rd Annual Moses Gunn Research Conference. Ann Arbor, MI. May 12, 2011.

60. Harris ME, Englesbe MJ, Sonnenday CJ. Frailty In Patients Referred For Liver Transplant Evaluation:

An Independent Domain Associated With Decreased Survival. University of Michigan Department of Surgery 23rd Annual Moses Gunn Research Conference. Ann Arbor, MI. May 12, 2011.

61. Friedman, J, Englesbe MJ, Sonnenday CJ. Frailty and Quality of Life in Candidates for Liver

Transplantion. University of Michigan Department of Surgery 23rd Annual Moses Gunn Research Conference. Ann Arbor, MI. May 12, 2011.

62. Tishburg L, Englesbe MJ, Sonnenday CJ. Depression is Associated with Frailty But Not Severity of Liver Disease Among Candidates for Liver Transplantation. University of Michigan Department of Surgery 23rd Annual Moses Gunn Research Conference. Ann Arbor, MI. May 12, 2011.

63. Kim EK, Terkmanian MN, Waits SA, Tishberg LM, Harbaugh CM, Sonnenday CJ, Englesbe, MJ.

Morphometric Age as a Predictor of Post-Liver Transplant Survival. Oral Presentation at American Society of Transplant Surgeons 11th Annual State-of-the-Art Winter Symposium, Miami, FL, January 2013.

64. Zarinsefat A, Terjimanian, MN, Tishberg LM, Stein IC, Mazurek, AA, Wang SC, Sonnenday CJ,

Englesbe, MJ. Perioperative Changes In Trunk Musculature As A Predictor Of One Year Mortality. Academic Surgical Congress, 8th Annual Meeting, New Orleans, LA. February 2013.

65. Sonnenday CJ, Englesbe MJ, and Volk ML. Frailty Score Predicts Outcome Among Liver Transplant

Candidates and Recipients. (Oral Presentation at the 64th American Association for the Study of Liver Diseases Annual Liver Meeting, Washington, DC, November 2013.

66. Derck J, Klemptner E, Mazurek A, Fakhoury J, and Sonnenday CJ. Prehabilitation for Patients With

End-Stage Liver Diease. Am J Transplant 2105;15(S1):99, P-123. (Poster Presentation at American Society of Transplant Surgeons 13th Annual State-of-the-Art Winter Symposium, Miami, FL, January 2015)

67. Juntila OC, Friedman J, Cron D, Terjimanian M, Lindquist M, Hammoud A, Alameddine M, Claflin J,

Englesbe M, Wang S, and Sonnenday CJ. Analytic Morphomics Predicts Body Composition


Associated with Diabetes. (Oral Presentation at Academic Surgical Congress, Las Vegas, NV, February 2015).

68. Friedman J, Fakhoury J, Cron DC, Derck J, Klei J, Englesbe MJ, and Sonnenday CJ. Impact Of Waitlist

Frailty On Liver Transplant Outcomes. (Plenary presentation at European Society of Transplantation, Brussels, Belgium, September 2015).

christopher j. sonnenday m.d., m.h.s. · 2019-10-18 · baltimore, md (july 1, 1998 – june 30,...

Documents